LCID
Lucid Group, Inc.
LCID has the edge over STKS overall, supported by stronger fundamentals and stronger modeled upside.
STKS
The ONE Group Hospitality, Inc.
STKS has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
STKS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Weak |
STKS's revenue and cash flow are currently stable, but its profitability and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
STKS PE Valuation
STKS has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
STKS Forward outlook
There aren't enough analyst estimates for STKS to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the stronger earnings trend. Trailing diluted EPS is down 224% for LCID versus STKS down 331%.
STKS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$0.80 | -633% |
| Q2 2024 | -$0.38 | -246% |
| Q1 2024 | $0.00 | -100% |
| Q4 2023 | $0.15 | -63% |
| Q3 2023 | $0.15 | -65% |
| Q2 2023 | $0.26 | -66% |
| Q1 2023 | $0.37 | -64% |
| Q4 2022 | $0.40 | -57% |
STKS lost $1.85 per share over the past year, a bigger loss than the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over STKS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
STKS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $177M | -1.8% |
| Q2 2026 | $200.5M | -3.3% |
| Q1 2026 | $212.8M | +0.8% |
| Q4 2025 | $207M | -6.7% |
| Q3 2025 | $180.2M | -7.1% |
| Q2 2025 | $207.4M | +20% |
| Q1 2025 | $211.1M | +148% |
| Q4 2024 | $221.9M | +147% |
STKS's revenue fell from its 2024 peak and has held roughly level since: $177M last quarter, down 1.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.3% | +1.1 points |
| Q2 2026 | 3.3% | +3 points |
| Q1 2026 | 6.5% | +1.5 points |
| Q4 2025 | 2.2% | -3.6 points |
| Q3 2025 | -4.4% | -2.8 points |
| Q2 2025 | 0.3% | -0.6 points |
| Q1 2025 | 5.1% | +5.8 points |
| Q4 2024 | 5.8% | +0.3 points |
STKS has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
STKS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.8M | +$3.3M |
| Q2 2026 | -$1.8M | +$13.2M |
| Q1 2026 | $11.7M | +$17.5M |
| Q4 2025 | -$329K | -145% |
| Q3 2025 | -$6.1M | -2238% |
| Q2 2025 | -$15M | +$8M |
| Q1 2025 | -$5.8M | -$388K |
| Q4 2024 | $733K | +77% |
STKS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
STKS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +175K shares |
| 1 year | +8.7% | +2.7M shares |
| 3 years | +6.8% | +2.1M shares |
| 5 years | -2.1% | -733K shares |
| Available history | +14% | +4M shares |
STKS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $201,000 |
| Q2 2025 | $598,000 |
| Q1 2025 | $307,000 |
| Q4 2024 | — |
| Q3 2024 | $2.3M |
| Q4 2023 | $193,000 |
| Q3 2023 | $3.5M |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
STKS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.3x | High |
| Q2 2026 | 5.5x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.6x | High |
| Q3 2025 | 5.6x | High |
| Q2 2025 | 5.3x | High |
| Q1 2025 | 5.2x | High |
| Q4 2024 | 6.8x | High |
STKS's net debt is about 5.3 years of its operating earnings (EBITDA), down from 5.6 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
STKS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.4 | Oversold |
| Stochastic | 8.9 | Oversold |
STKS's weekly RSI is 27 (oversold) and its Stochastic is 9 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
STKS PE vs Consumer Cyclical Sector
| Metric | STKS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
STKS has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
STKS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.30 | 18% below |
| 20 week MA | $1.58 | 33% below |
| 50 week MA | $1.80 | 41% below |
| 100 week MA | $2.42 | 56% below |
| 200 week MA | $3.98 | 73% below |
STKS is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
STKS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.37 | $3.56 | +5.6% |
| 2021 | $3.56 | $12.8 | +260% |
| 2022 | $12.8 | $6.36 | -50% |
| 2023 | $6.36 | $6.12 | -3.8% |
| 2024 | $6.12 | $2.91 | -52% |
| 2025 | $2.91 | $1.80 | -38% |
| 2026 YTD | $1.80 | $1.06 | -41% |
STKS has the edge over LCID on returns for 2026, with the stronger performance.